For patients who have tried chiropractic care, physical therapy, cortisone injections, and conservative management over months or years with limited progress, the conversation eventually turns to something different. One option that comes up with increasing regularity is stem cell therapy in Colombia. This is not a fringe idea at this point. It is a structured medical procedure, performed by trained physicians at credentialed facilities, and several hundred American patients travel to Colombia for it every year.
At Spine and Wellness Center Lakewood Ranch, we have a formal partnership with a Colombia-based regenerative medicine program. Dr. Banman works directly with patients before and after the procedure to coordinate care, confirm candidacy, and integrate the cellular therapy into a broader recovery plan. This article explains what that looks like from the patient's perspective.
Why Patients With Chronic Pain Look Beyond Standard Care
Most people who explore regenerative travel are not impulsive. They have typically been dealing with a chronic condition for one to five years. They have had imaging done. They understand their diagnosis. And they have already completed at least one full course of conservative care without achieving the level of improvement they were hoping for.
The conditions we most commonly see in this population include:
- Moderate to severe knee osteoarthritis, particularly where joint replacement has been discussed but the patient wants to exhaust non-surgical options first
- Hip osteoarthritis with significant cartilage loss
- Chronic disc injuries with persistent nerve involvement that has not fully resolved with decompression and rehabilitation
- Shoulder pathology including rotator cuff degeneration or labral damage
- Systemic inflammatory conditions affecting multiple joints
What drives them to look beyond what is available locally is usually a combination of three things: the US regulatory environment limits the types of stem cell protocols approved for use outside of clinical trials, the cost differential between Colombia and comparable US clinics is substantial, and the physician network in Colombia has accumulated significant experience performing these procedures over more than a decade.
What Stem Cell Therapy Actually Does
Stem cell therapy in this context refers to procedures that introduce biologic material, typically derived from the patient's own body or from carefully screened donor sources, into damaged tissue to support the body's natural repair processes. The most common protocols used in Colombia involve one or more of the following:
- Platelet-Rich Plasma (PRP): Concentrated growth factors from the patient's own blood, injected directly into the affected joint or disc. A well-established procedure with a strong safety record.
- Bone Marrow Aspirate Concentrate (BMAC): Stem cells drawn from the patient's own iliac crest, concentrated and re-injected. More intensive than PRP and typically reserved for more advanced degeneration.
- Wharton's Jelly-Derived Mesenchymal Stem Cells: Cells from screened umbilical cord tissue. Regulations in Colombia permit clinical use of this protocol under physician supervision; the equivalent is currently available in the United States only through IRB-approved trials.
The goal of each of these approaches is the same: to introduce biologic signals that may reduce inflammation, support tissue remodeling, and improve the environment around the damaged structure. These procedures do not rebuild cartilage overnight and they are not a substitute for rehabilitation. Many patients report meaningful functional improvement over three to twelve months following the procedure, though individual responses vary considerably.
Regenerative medicine works with your body's existing repair capacity. The procedure introduces the signals; the recovery period is when the biology happens. Patients who combine the procedure with structured rehabilitation, spinal decompression for disc cases, and appropriate nutrition support tend to report better outcomes than those who treat it as a standalone fix.
Why Colombia Has Become a Destination for Regenerative Medicine
Colombia's position in regenerative medicine is not accidental. Starting in the early 2010s, the country developed a regulatory framework under INVIMA (Colombia's equivalent of the FDA) that allowed physicians to offer certain cell-based therapies as clinical procedures rather than requiring them to be classified as investigational drugs. This opened the door for experienced physicians to develop real-world protocols with real-world patient populations.
Over the following decade, Colombia built a cluster of credentialed clinics, primarily in Medellín and Bogotá, that have treated thousands of patients including a large proportion of medical travelers from the United States. The combination of physician experience, modern facilities, regulatory permission to use protocols not yet available in the US, and costs that typically run 40 to 70 percent lower than comparable US private pay programs has made Colombia the leading destination for this type of care in the Western Hemisphere.
Quality does vary between clinics. The facilities in our partner network have been personally vetted by Dr. Banman, carry appropriate accreditation, use laboratory-verified biologic materials, and have transparent intake and follow-up protocols. We do not refer patients to clinics we have not reviewed directly.
Who Tends to Be a Good Candidate
Candidacy is determined through a structured evaluation before any travel is booked. Not every patient who asks about stem cell therapy is appropriate for it, and identifying poor candidates before the procedure is as important as identifying good ones. Generally, patients who tend to benefit most share several characteristics:
- Age and tissue quality: Patients in their 40s through early 70s with moderate rather than end-stage degeneration typically see the most meaningful responses. Very advanced joint destruction (Kellgren-Lawrence grade 4 with bone-on-bone contact) leaves less viable tissue for the biologic signals to work with.
- Absence of active infection or systemic autoimmune disease in active flare: These conditions can interfere with the procedure's effectiveness and may increase risk.
- Non-smoker or minimal smoking history: Smoking impairs the vascular and cellular environment that regenerative procedures rely on.
- Commitment to the rehabilitation window: The three to six months following the procedure are critical. Patients who understand this and plan their recovery accordingly do better than those expecting the procedure to work independently.
- Realistic expectations: Regenerative therapy is not a cure for structural degeneration. The goal is meaningful functional improvement, pain reduction, and in some cases delaying or avoiding more invasive procedures. Patients who understand this framing tend to report higher satisfaction regardless of the degree of change.
For disc-related conditions, candidacy assessment also includes evaluating whether spinal decompression and other conservative care has been appropriately exhausted first, since many disc cases that appear to need biologic intervention improve substantially with a proper decompression protocol before any travel is considered.
What the Process Looks Like From Start to Finish
Patients who go through our program follow a structured sequence rather than simply booking a flight and showing up at a clinic. Here is how it typically unfolds:
- Initial evaluation at our Lakewood Ranch office: Dr. Banman reviews the patient's imaging, history, prior treatments, and current functional status. If the patient appears to be a viable candidate, a detailed candidacy report is prepared for our Colombia partners.
- Consultation with the Colombia physician team: The partner clinic reviews the report and either confirms candidacy, requests additional imaging, or declines and explains why. This step filters out patients who are not appropriate before any travel is booked.
- Pre-procedure preparation: Depending on the protocol, patients may complete specific nutritional preparation, medication adjustments (particularly for anti-inflammatories that can blunt the biologic response), or a pre-procedure round of supportive therapies at our office.
- Travel and procedure: The procedure itself is typically performed over two to five days depending on the protocol. Patients generally spend one to two weeks in Colombia total. The Colombia team manages all clinical aspects during this window.
- Return and structured follow-up: This is where our role becomes primary again. Post-procedure rehabilitation, monitoring for expected response patterns, and integration of supportive therapies such as spinal decompression for disc cases or Class IV laser for joint cases all happen at our Lakewood Ranch office over the following months.
How Dr. Banman Supports the Full Care Continuum
The Colombia procedure is one component of a longer care arc. What happens before the trip and after the return often determines whether the biologic intervention reaches its potential. Dr. Banman's role in this program is built around that reality.
Before the procedure, the focus is on optimizing the patient's tissue environment: addressing compensatory movement patterns that are loading the damaged structure abnormally, reducing background inflammation through appropriate therapeutic modalities, and establishing a baseline so that post-procedure changes can be objectively tracked.
After the return, the focus shifts to supporting the remodeling window. In joint cases, this typically involves controlled loading protocols and Class IV laser. In disc cases, it often includes continued spinal decompression to maintain the hydration and nutrition gradients that support disc tissue. In cases with significant nerve involvement, the ReBuilder neuropathy protocol may be incorporated to support nerve function recovery.
Our goal in each case is a care plan that treats the Colombia procedure as a catalyst, not a conclusion. The patients who do best are those who approach the full program with the same commitment they brought to deciding to travel in the first place. If you are interested in our regenerative medicine program, the first step is a candidacy evaluation at our office.
Questions Patients Ask Before They Go
Is it safe? Like any medical procedure, it carries risk. The partner clinics we work with have strong safety records and transparent adverse event data. Serious complications are rare. The most common experiences are temporary soreness at the injection site and a brief inflammatory response in the days following the procedure, which is actually expected and indicates biologic activity.
Will insurance cover it? In most cases, no. Regenerative procedures of this type are considered investigational by most US insurers regardless of where they are performed. Patients should plan for this as an out-of-pocket expense.
How long before I see results? The honest answer is that the response timeline varies. Some patients report noticeable improvement within four to six weeks. For others, the more significant changes come at three to six months as the remodeling process progresses. We track patients actively during this window so that the care plan can be adjusted based on actual response.
Can I combine this with other treatments at your office? Yes, and in most cases we recommend it. Therapies like regenerative medicine, laser, and spinal decompression work through different mechanisms and are designed to complement each other rather than compete. Dr. Banman structures the post-procedure plan around the specific combination that fits the patient's condition and response.
